said Monday it has regained compliance for continued listing on Nasdaq through the recent sale of about 24.3 million shares of stock. The Redwood City-based specialty pharmaceutical company (NASDAQ:APPA) said the stock, sold at $1.
65 a share, brings it in line with Nasdaq's minimum stockholders' equity requirement . Pharma said it was told by Nasdaq that it was out of compliance with the minimum $10 million stockholders' equity requirement. The company said it also submitted a specific plan to Nasdaq about how it will achieve and sustain compliance with all listing requirements, including the minimum shareholders' equity standard.
Subscribe or renew online Genzyme gets new FDA approval on Carticel said Monday it has regained compliance for continued listing on Nasdaq through the recent sale of about 24.3 million shares of stock.
News RSS